Clinical trial
A Prospective, Randomized, Controlled Superiority Study to Evaluate Use of the PEAK PlasmaBlade 4.0 in Total Knee Replacement
NCT01081886 is registered in ClinicalTrials.gov with Medtronic Surgical Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled Superiority Study to Evaluate Use of the PEAK PlasmaBlade 4.0 in Total Knee Replacement
- Lead sponsor
- Medtronic Surgical Technologies
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2010
- Completion date
- September 30, 2011
- Enrollment
- 24 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative joint disease, osteoarthritis